AnalystsPete StavropoulosPete Stavropoulos's Stock Forecasts
AnalystsPete Stavropoulos
Sectors:
Industries:
Analyst Ranking
Top 13%
#613 out of 4873 analysts
Average Return
+18.62%
Win Rate
33%10 out of 30
Risk vs Reward
Poor
Good
Pete Stavropoulos's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Immunome IncIMNM | +326.19% | $5.65 | $24.08 | 2023-03-19 - 2024-03-19 | Strong Buy |
Rezolute IncRZLT | +238.19% | $1.44 | $4.87 | 2023-09-18 - 2024-09-18 | Strong Buy |
Orchard Therapeutics PLCORTX | +229.39% | $5.07 | $16.70 | 2023-03-27 - 2024-01-23 | Strong Buy |
Rezolute IncRZLT | +100.50% | $2.00 | $4.01 | 2023-06-27 - 2024-06-27 | Strong Buy |
Annexon IncANNX | +100.34% | $2.95 | $5.91 | 2023-08-21 - 2024-08-21 | Strong Buy |
Pete Stavropoulos Analyst Color
Get additional color on Pete Stavropoulos's coverage of popular stocks
Pete Stavropoulos's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Vera Therapeutics IncVERA | 7 | Strong Buy | $100.00 | +353.93% | Maintains | 2 days ago |
Voyager Therapeutics IncVYGR | 1 | Strong Buy | $5.73 | +67.06% | Initiates Coverage On | 4 months ago |
Jasper Therapeutics IncJSPR | 3 | Strong Buy | $60.00 | N/A | Reiterates | 2 years ago |
Alector IncALEC | 1 | Strong Buy | $13.00 | N/A | Initiates Coverage On | 2 years ago |
Rezolute IncRZLT | 3 | Strong Buy | $5.00 | N/A | Reiterates | 2 years ago |
Pliant Therapeutics IncPLRX | 3 | Strong Buy | $63.00 | N/A | Reiterates | 2 years ago |
Arcturus Therapeutics Holdings IncARCT | 3 | Strong Buy | $54.00 | N/A | Reiterates | 2 years ago |
Annexon IncANNX | 5 | Strong Buy | $13.00 | N/A | Reiterates | 2 years ago |
Acumen Pharmaceuticals IncABOS | 2 | Strong Buy | $13.00 | N/A | Reiterates | 2 years ago |
Orchard Therapeutics PLCORTX | 2 | Strong Buy | $15.00 | N/A | Reiterates | 2 years ago |
Immunome IncIMNM | 1 | Strong Buy | $8.00 | N/A | Reiterates | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.